| |
| Device | CyPass Micro-Stent |
| Generic Name | Intraocular pressure lowering implant |
| Applicant | Alcon Research, Ltd. 6201 S. Fwy. Fort Worth, TX 76134 |
| PMA Number | P150037 |
| Supplement Number | S014 |
| Date Received | 12/20/2019 |
| Decision Date | 04/09/2020 |
| Withdrawal Date | 12/14/2023 |
| Product Code |
OGO |
| Advisory Committee |
Ophthalmic |
| Supplement Type | Normal 180 Day Track No User Fee |
| Supplement Reason | Postapproval Study Protocol |
| Expedited Review Granted? | No |
| Combination Product | No |
| Predetermined Change Control Plan Authorized | No |
Approval Order Statement Approval of the protocol for the post-approval study (PAS) referenced above. The PAS protocol has been submitted to comply with the letter dated October 10, 2019 requesting that you continue the assessment of subjects implanted with the device for a minimum of 10 years to assess the long-term safety profile of the CyPass® System. |